 David Allen
Concepts (455)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myostatin | 9 | 2011 | 25 | 2.250 |
Why?
| | Muscle, Skeletal | 34 | 2015 | 1644 | 2.030 |
Why?
| | Muscle Fibers, Skeletal | 16 | 2011 | 203 | 1.900 |
Why?
| | Myosin Heavy Chains | 18 | 2011 | 188 | 1.750 |
Why?
| | Antigens, Human Platelet | 7 | 2013 | 9 | 1.400 |
Why?
| | Isoantibodies | 6 | 2013 | 57 | 1.140 |
Why?
| | Food Deprivation | 4 | 2010 | 25 | 1.110 |
Why?
| | Gene Expression Regulation | 11 | 2010 | 2545 | 1.000 |
Why?
| | Muscular Atrophy | 4 | 2010 | 75 | 0.980 |
Why?
| | Muscle Fibers, Fast-Twitch | 7 | 2010 | 17 | 0.910 |
Why?
| | Physical Conditioning, Animal | 7 | 2020 | 236 | 0.900 |
Why?
| | Promoter Regions, Genetic | 12 | 2010 | 1213 | 0.900 |
Why?
| | Adaptation, Physiological | 9 | 2011 | 521 | 0.890 |
Why?
| | Matrix Metalloproteinase 9 | 4 | 2013 | 124 | 0.830 |
Why?
| | Hindlimb | 6 | 2011 | 126 | 0.690 |
Why?
| | Calcineurin | 5 | 2010 | 103 | 0.650 |
Why?
| | Integrin beta3 | 4 | 2013 | 10 | 0.590 |
Why?
| | Blood Platelets | 3 | 2011 | 386 | 0.560 |
Why?
| | Transcription, Genetic | 8 | 2020 | 1416 | 0.560 |
Why?
| | Edetic Acid | 3 | 2013 | 49 | 0.530 |
Why?
| | Thrombocytopenia, Neonatal Alloimmune | 2 | 2013 | 2 | 0.520 |
Why?
| | Myoblasts | 3 | 2008 | 84 | 0.510 |
Why?
| | Exercise | 4 | 2015 | 1934 | 0.500 |
Why?
| | Hindlimb Suspension | 4 | 2010 | 19 | 0.500 |
Why?
| | Mice | 35 | 2011 | 16983 | 0.480 |
Why?
| | RNA, Messenger | 14 | 2010 | 2703 | 0.470 |
Why?
| | Transforming Growth Factor beta | 3 | 2008 | 462 | 0.460 |
Why?
| | Elbow Joint | 2 | 2015 | 67 | 0.460 |
Why?
| | Space Flight | 4 | 2008 | 84 | 0.450 |
Why?
| | Animals | 54 | 2020 | 35409 | 0.440 |
Why?
| | Muscle Development | 5 | 2010 | 108 | 0.430 |
Why?
| | Integrin alpha2 | 1 | 2013 | 3 | 0.420 |
Why?
| | Weightlessness | 4 | 2008 | 45 | 0.410 |
Why?
| | Chelating Agents | 1 | 2013 | 69 | 0.410 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2011 | 24 | 0.390 |
Why?
| | Iron Chelating Agents | 1 | 2011 | 19 | 0.380 |
Why?
| | Organ Size | 12 | 2010 | 456 | 0.370 |
Why?
| | Dexamethasone | 2 | 2010 | 352 | 0.360 |
Why?
| | Transcription Factors | 6 | 2020 | 1645 | 0.350 |
Why?
| | Molecular Sequence Data | 10 | 2010 | 2833 | 0.350 |
Why?
| | CCAAT-Enhancer-Binding Protein-delta | 1 | 2010 | 6 | 0.350 |
Why?
| | Tolloid-Like Metalloproteinases | 1 | 2010 | 1 | 0.350 |
Why?
| | Bone Morphogenetic Protein 1 | 1 | 2010 | 1 | 0.350 |
Why?
| | Smad Proteins | 2 | 2010 | 40 | 0.350 |
Why?
| | Elbow | 1 | 2011 | 56 | 0.340 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2010 | 88 | 0.330 |
Why?
| | Mice, Inbred C57BL | 12 | 2011 | 5468 | 0.320 |
Why?
| | Epitopes | 2 | 2011 | 474 | 0.320 |
Why?
| | Physical Exertion | 5 | 2015 | 210 | 0.310 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 2008 | 88 | 0.300 |
Why?
| | DNA, Intergenic | 1 | 2008 | 25 | 0.290 |
Why?
| | Activin Receptors, Type II | 1 | 2008 | 12 | 0.290 |
Why?
| | Adipose Tissue | 3 | 2011 | 594 | 0.290 |
Why?
| | Motor Activity | 7 | 2005 | 684 | 0.290 |
Why?
| | Genes, MHC Class II | 1 | 2008 | 73 | 0.290 |
Why?
| | CLOCK Proteins | 2 | 2020 | 8 | 0.290 |
Why?
| | Base Sequence | 7 | 2010 | 2142 | 0.290 |
Why?
| | Protein Isoforms | 7 | 2008 | 393 | 0.290 |
Why?
| | Muscle Fibers, Slow-Twitch | 5 | 2010 | 15 | 0.270 |
Why?
| | Antibodies, Monoclonal | 4 | 2011 | 1368 | 0.270 |
Why?
| | Genotype | 4 | 2011 | 1829 | 0.270 |
Why?
| | MicroRNAs | 2 | 2010 | 680 | 0.260 |
Why?
| | Obesity | 2 | 2011 | 2885 | 0.260 |
Why?
| | Drosophila Proteins | 3 | 2020 | 187 | 0.260 |
Why?
| | Transfection | 7 | 2008 | 918 | 0.260 |
Why?
| | Cell Nucleus | 7 | 2001 | 590 | 0.260 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2007 | 113 | 0.250 |
Why?
| | Circadian Rhythm | 3 | 2020 | 416 | 0.250 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 836 | 0.250 |
Why?
| | Interleukin-6 | 1 | 2009 | 724 | 0.240 |
Why?
| | Forkhead Transcription Factors | 1 | 2006 | 184 | 0.240 |
Why?
| | Calcium Signaling | 2 | 2009 | 252 | 0.240 |
Why?
| | Muscular Diseases | 2 | 2011 | 109 | 0.240 |
Why?
| | Purpura, Thrombocytopenic | 1 | 2004 | 4 | 0.230 |
Why?
| | Platelet Transfusion | 2 | 2004 | 61 | 0.230 |
Why?
| | Serum Response Factor | 1 | 2005 | 32 | 0.230 |
Why?
| | Insulin-Like Growth Factor I | 5 | 2003 | 310 | 0.230 |
Why?
| | DNA-Binding Proteins | 4 | 2009 | 1441 | 0.230 |
Why?
| | Growth Hormone | 4 | 1998 | 100 | 0.220 |
Why?
| | Physical Endurance | 2 | 2002 | 264 | 0.220 |
Why?
| | Cells, Cultured | 8 | 2010 | 4102 | 0.220 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2011 | 2062 | 0.210 |
Why?
| | Infant, Newborn, Diseases | 1 | 2004 | 111 | 0.210 |
Why?
| | Cell Differentiation | 3 | 2010 | 1900 | 0.210 |
Why?
| | Growth Substances | 1 | 2002 | 148 | 0.200 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 954 | 0.200 |
Why?
| | Proteins | 1 | 2008 | 944 | 0.190 |
Why?
| | Matrix Metalloproteinases | 1 | 2002 | 91 | 0.190 |
Why?
| | Stress, Psychological | 1 | 2010 | 1070 | 0.190 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 182 | 0.190 |
Why?
| | Male | 26 | 2022 | 63759 | 0.190 |
Why?
| | Rats | 12 | 2011 | 5487 | 0.180 |
Why?
| | Nuclear Proteins | 3 | 2006 | 660 | 0.180 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2006 | 820 | 0.180 |
Why?
| | Cell Line | 5 | 2010 | 2780 | 0.180 |
Why?
| | Mice, Transgenic | 5 | 2011 | 2135 | 0.170 |
Why?
| | Circadian Clocks | 1 | 2020 | 46 | 0.170 |
Why?
| | Heart | 4 | 2005 | 645 | 0.170 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2020 | 42 | 0.170 |
Why?
| | Histone Acetyltransferases | 1 | 2020 | 61 | 0.160 |
Why?
| | Acclimatization | 1 | 2001 | 166 | 0.160 |
Why?
| | Proteomics | 3 | 2020 | 1058 | 0.160 |
Why?
| | Binding Sites | 5 | 2007 | 1251 | 0.160 |
Why?
| | Drosophila | 1 | 2020 | 141 | 0.160 |
Why?
| | Corticosterone | 2 | 2010 | 220 | 0.160 |
Why?
| | Bariatric Surgery | 1 | 2022 | 197 | 0.160 |
Why?
| | Fibronectins | 4 | 2002 | 127 | 0.150 |
Why?
| | Mutation | 4 | 2011 | 3706 | 0.150 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 7 | 2009 | 338 | 0.150 |
Why?
| | Weight-Bearing | 3 | 2001 | 165 | 0.150 |
Why?
| | Muscle Proteins | 2 | 2010 | 222 | 0.150 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2011 | 2444 | 0.140 |
Why?
| | Thrombocytopenia | 3 | 2004 | 189 | 0.130 |
Why?
| | Luciferases | 2 | 2008 | 147 | 0.130 |
Why?
| | Calcium | 1 | 2002 | 1212 | 0.130 |
Why?
| | NFATC Transcription Factors | 2 | 2009 | 86 | 0.130 |
Why?
| | Protein Binding | 3 | 2020 | 2123 | 0.130 |
Why?
| | Glucocorticoids | 2 | 2010 | 582 | 0.130 |
Why?
| | Mice, Knockout | 5 | 2010 | 2888 | 0.120 |
Why?
| | Staphylococcus aureus | 2 | 2011 | 436 | 0.120 |
Why?
| | Fluorescent Antibody Technique | 2 | 2009 | 377 | 0.120 |
Why?
| | Humans | 32 | 2022 | 129847 | 0.120 |
Why?
| | Female | 22 | 2022 | 68829 | 0.120 |
Why?
| | Microscopy, Confocal | 6 | 2001 | 318 | 0.120 |
Why?
| | Body Weight | 6 | 2003 | 947 | 0.120 |
Why?
| | Genetic Variation | 4 | 2007 | 937 | 0.110 |
Why?
| | Hypertrophy | 3 | 2001 | 125 | 0.110 |
Why?
| | Signal Transduction | 5 | 2009 | 4935 | 0.110 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2013 | 26 | 0.110 |
Why?
| | Immunoassay | 1 | 1994 | 108 | 0.110 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2006 | 363 | 0.110 |
Why?
| | Bacterial Proteins | 2 | 2011 | 838 | 0.110 |
Why?
| | Aging | 2 | 2001 | 1774 | 0.110 |
Why?
| | Amino Acid Sequence | 5 | 2009 | 2057 | 0.100 |
Why?
| | Infant, Newborn | 5 | 2013 | 5772 | 0.100 |
Why?
| | Species Specificity | 2 | 2020 | 568 | 0.100 |
Why?
| | Isometric Contraction | 2 | 2015 | 187 | 0.100 |
Why?
| | Immunity, Maternally-Acquired | 1 | 1992 | 19 | 0.100 |
Why?
| | Range of Motion, Articular | 2 | 2015 | 370 | 0.100 |
Why?
| | Education | 1 | 2013 | 104 | 0.100 |
Why?
| | Vancomycin Resistance | 2 | 2011 | 14 | 0.100 |
Why?
| | Blotting, Western | 3 | 2010 | 1204 | 0.100 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1514 | 0.100 |
Why?
| | Apoptosis | 2 | 1999 | 2489 | 0.100 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1847 | 0.090 |
Why?
| | Time Factors | 3 | 2010 | 6550 | 0.090 |
Why?
| | Gluconeogenesis | 2 | 2010 | 78 | 0.090 |
Why?
| | Weight Loss | 2 | 2022 | 740 | 0.090 |
Why?
| | Antigen-Antibody Complex | 1 | 2011 | 86 | 0.090 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2008 | 151 | 0.090 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2011 | 72 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 6 | 2003 | 2403 | 0.090 |
Why?
| | Genes, Bacterial | 2 | 2008 | 159 | 0.090 |
Why?
| | Running | 1 | 2013 | 224 | 0.090 |
Why?
| | Protein Kinase C | 2 | 2002 | 262 | 0.090 |
Why?
| | Muscle Fatigue | 2 | 2011 | 101 | 0.090 |
Why?
| | Quality of Life | 1 | 2022 | 2695 | 0.090 |
Why?
| | Torque | 1 | 2011 | 83 | 0.090 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2010 | 8 | 0.090 |
Why?
| | Glucokinase | 1 | 2010 | 14 | 0.090 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 32 | 0.090 |
Why?
| | Tripartite Motif Proteins | 1 | 2010 | 33 | 0.090 |
Why?
| | Proteome | 2 | 2007 | 440 | 0.080 |
Why?
| | 3T3 Cells | 3 | 2008 | 159 | 0.080 |
Why?
| | DNA | 4 | 2008 | 1406 | 0.080 |
Why?
| | Mice, Obese | 2 | 2008 | 63 | 0.080 |
Why?
| | Phosphatidylethanolamine Binding Protein | 1 | 2009 | 1 | 0.080 |
Why?
| | Oxazolidinones | 1 | 2009 | 15 | 0.080 |
Why?
| | Immunohistochemistry | 5 | 2003 | 1690 | 0.080 |
Why?
| | Thymus Gland | 1 | 2010 | 309 | 0.080 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2010 | 157 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2008 | 434 | 0.080 |
Why?
| | Body Temperature Regulation | 2 | 2007 | 97 | 0.070 |
Why?
| | Skeletal Muscle Myosins | 1 | 2008 | 2 | 0.070 |
Why?
| | RNA, Antisense | 1 | 2008 | 16 | 0.070 |
Why?
| | Follistatin-Related Proteins | 1 | 2008 | 1 | 0.070 |
Why?
| | Calcium-Binding Proteins | 1 | 2009 | 213 | 0.070 |
Why?
| | Myogenic Regulatory Factors | 2 | 2005 | 58 | 0.070 |
Why?
| | MEF2 Transcription Factors | 2 | 2005 | 62 | 0.070 |
Why?
| | Spleen | 1 | 2010 | 508 | 0.070 |
Why?
| | Adult | 8 | 2022 | 35634 | 0.070 |
Why?
| | Models, Animal | 1 | 2009 | 376 | 0.070 |
Why?
| | ADP Ribose Transferases | 1 | 2007 | 9 | 0.070 |
Why?
| | Creatine Kinase | 3 | 2015 | 75 | 0.070 |
Why?
| | Muscle Contraction | 1 | 2011 | 423 | 0.070 |
Why?
| | Eating | 1 | 2010 | 372 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2010 | 1291 | 0.070 |
Why?
| | Multigene Family | 1 | 2008 | 195 | 0.070 |
Why?
| | Point Mutation | 1 | 2008 | 224 | 0.070 |
Why?
| | Cluster Analysis | 1 | 2008 | 483 | 0.070 |
Why?
| | Up-Regulation | 1 | 2010 | 836 | 0.070 |
Why?
| | Cloning, Molecular | 1 | 2008 | 524 | 0.070 |
Why?
| | Adolescent | 5 | 2022 | 20451 | 0.070 |
Why?
| | Leptin | 1 | 2008 | 222 | 0.070 |
Why?
| | Protein Kinases | 1 | 2008 | 318 | 0.070 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 362 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2009 | 443 | 0.070 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 756 | 0.070 |
Why?
| | Forkhead Box Protein O1 | 1 | 2006 | 22 | 0.060 |
Why?
| | NF-kappa B | 1 | 2010 | 666 | 0.060 |
Why?
| | Cerebrospinal Fluid | 1 | 2007 | 92 | 0.060 |
Why?
| | Myogenic Regulatory Factor 5 | 1 | 2006 | 7 | 0.060 |
Why?
| | Animals, Newborn | 4 | 2001 | 834 | 0.060 |
Why?
| | MyoD Protein | 1 | 2006 | 33 | 0.060 |
Why?
| | Feeding Behavior | 2 | 2022 | 626 | 0.060 |
Why?
| | Dietary Fats | 1 | 2008 | 303 | 0.060 |
Why?
| | Anti-Inflammatory Agents | 1 | 2009 | 482 | 0.060 |
Why?
| | Young Adult | 4 | 2022 | 12467 | 0.060 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2008 | 398 | 0.060 |
Why?
| | Statistics as Topic | 1 | 2007 | 306 | 0.060 |
Why?
| | Genes, Reporter | 2 | 2006 | 266 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1033 | 0.060 |
Why?
| | Cattle | 1 | 2008 | 978 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2008 | 3089 | 0.060 |
Why?
| | Octamer Transcription Factor-1 | 1 | 2005 | 5 | 0.060 |
Why?
| | Tobacco Use Disorder | 1 | 2007 | 237 | 0.060 |
Why?
| | Mice, Inbred Strains | 2 | 2002 | 408 | 0.060 |
Why?
| | Microspheres | 1 | 2005 | 131 | 0.060 |
Why?
| | Myocardium | 3 | 2005 | 983 | 0.060 |
Why?
| | Biomarkers | 3 | 2013 | 3971 | 0.060 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2007 | 324 | 0.060 |
Why?
| | Immunoglobulins | 1 | 2005 | 162 | 0.060 |
Why?
| | Receptors, Nicotinic | 1 | 2007 | 329 | 0.060 |
Why?
| | Tissue Distribution | 1 | 2005 | 316 | 0.060 |
Why?
| | Life Style | 1 | 2007 | 462 | 0.060 |
Why?
| | Affect | 1 | 2007 | 289 | 0.060 |
Why?
| | Drosophila melanogaster | 2 | 2014 | 211 | 0.050 |
Why?
| | Oligonucleotides | 1 | 2005 | 146 | 0.050 |
Why?
| | Plasmids | 1 | 2005 | 360 | 0.050 |
Why?
| | Cell Count | 3 | 2002 | 318 | 0.050 |
Why?
| | Desmin | 1 | 2003 | 25 | 0.050 |
Why?
| | Phenotype | 5 | 2007 | 3062 | 0.050 |
Why?
| | Blood Proteins | 1 | 2005 | 245 | 0.050 |
Why?
| | Green Fluorescent Proteins | 1 | 2005 | 390 | 0.050 |
Why?
| | Gene Deletion | 1 | 2005 | 380 | 0.050 |
Why?
| | Peptide Fragments | 2 | 2000 | 695 | 0.050 |
Why?
| | Liver | 1 | 2011 | 1839 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2002 | 19 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2005 | 366 | 0.050 |
Why?
| | Gene Transfer Techniques | 2 | 2003 | 164 | 0.050 |
Why?
| | Calcimycin | 1 | 2002 | 49 | 0.050 |
Why?
| | Ionophores | 1 | 2002 | 23 | 0.050 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2002 | 56 | 0.050 |
Why?
| | Gene Expression | 4 | 2020 | 1465 | 0.050 |
Why?
| | Enhancer Elements, Genetic | 2 | 2001 | 177 | 0.050 |
Why?
| | Heart Rate | 1 | 2007 | 804 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2009 | 1205 | 0.050 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2002 | 85 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2005 | 844 | 0.050 |
Why?
| | Calcineurin Inhibitors | 1 | 2002 | 69 | 0.050 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2002 | 36 | 0.050 |
Why?
| | Selection, Genetic | 1 | 1984 | 252 | 0.050 |
Why?
| | Motivation | 1 | 2007 | 548 | 0.050 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2009 | 140 | 0.050 |
Why?
| | Molecular Biology | 1 | 2002 | 57 | 0.050 |
Why?
| | Mice, SCID | 1 | 2002 | 350 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2004 | 569 | 0.050 |
Why?
| | Brain Injuries | 1 | 2007 | 466 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1686 | 0.050 |
Why?
| | Antibodies | 1 | 2004 | 399 | 0.050 |
Why?
| | Cytokines | 1 | 2009 | 2022 | 0.050 |
Why?
| | NADH Tetrazolium Reductase | 1 | 2001 | 2 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2011 | 1708 | 0.050 |
Why?
| | Phosphorylation | 3 | 2014 | 1716 | 0.050 |
Why?
| | Isoenzymes | 1 | 2002 | 301 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2009 | 1937 | 0.050 |
Why?
| | Gravitation | 1 | 2001 | 16 | 0.050 |
Why?
| | Child Abuse | 1 | 2007 | 513 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2002 | 312 | 0.040 |
Why?
| | Cell Movement | 2 | 2002 | 950 | 0.040 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2007 | 113 | 0.040 |
Why?
| | Sarcomeres | 1 | 2001 | 93 | 0.040 |
Why?
| | Homozygote | 1 | 2001 | 195 | 0.040 |
Why?
| | Chemotactic Factors | 1 | 2000 | 55 | 0.040 |
Why?
| | Blood Glucose | 1 | 2010 | 2103 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2002 | 314 | 0.040 |
Why?
| | Animal Care Committees | 1 | 2020 | 6 | 0.040 |
Why?
| | Diet | 1 | 2008 | 1212 | 0.040 |
Why?
| | Factor IX | 1 | 2000 | 43 | 0.040 |
Why?
| | Heterozygote | 1 | 2001 | 271 | 0.040 |
Why?
| | Dependovirus | 1 | 2000 | 64 | 0.040 |
Why?
| | Antigen-Antibody Reactions | 2 | 2002 | 54 | 0.040 |
Why?
| | Transgenes | 1 | 2000 | 178 | 0.040 |
Why?
| | Propionates | 1 | 1999 | 38 | 0.040 |
Why?
| | Antigens, CD | 1 | 2002 | 487 | 0.040 |
Why?
| | Reference Values | 1 | 2001 | 796 | 0.040 |
Why?
| | Myosins | 2 | 2000 | 134 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2002 | 827 | 0.040 |
Why?
| | RNA Interference | 1 | 2020 | 451 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2000 | 312 | 0.040 |
Why?
| | Period Circadian Proteins | 2 | 2014 | 16 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2009 | 1160 | 0.040 |
Why?
| | Oligopeptides | 1 | 2000 | 260 | 0.040 |
Why?
| | Cats | 2 | 1995 | 207 | 0.040 |
Why?
| | Genes, Insect | 1 | 1997 | 22 | 0.030 |
Why?
| | Wound Healing | 1 | 2000 | 308 | 0.030 |
Why?
| | Alcoholism | 1 | 1984 | 766 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2008 | 371 | 0.030 |
Why?
| | Cytoplasm | 1 | 1997 | 269 | 0.030 |
Why?
| | Cell Wall | 2 | 2011 | 57 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 1997 | 1311 | 0.030 |
Why?
| | DNA, Bacterial | 2 | 2008 | 323 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2000 | 508 | 0.030 |
Why?
| | Myalgia | 1 | 2015 | 13 | 0.030 |
Why?
| | Visual Analog Scale | 1 | 2015 | 30 | 0.030 |
Why?
| | Chromatography, Liquid | 2 | 2009 | 426 | 0.030 |
Why?
| | Decerebrate State | 1 | 1995 | 4 | 0.030 |
Why?
| | Myosin Subfragments | 1 | 1995 | 22 | 0.030 |
Why?
| | Staphylococcal Infections | 2 | 2011 | 391 | 0.030 |
Why?
| | Escherichia coli | 1 | 1999 | 766 | 0.030 |
Why?
| | Atrophy | 1 | 1995 | 170 | 0.030 |
Why?
| | Isoantigens | 1 | 1994 | 14 | 0.030 |
Why?
| | ARNTL Transcription Factors | 1 | 2014 | 17 | 0.030 |
Why?
| | Antibody Specificity | 1 | 1994 | 185 | 0.030 |
Why?
| | Receptors, Somatotropin | 1 | 1993 | 9 | 0.030 |
Why?
| | United Kingdom | 1 | 1994 | 258 | 0.030 |
Why?
| | Immunosorbent Techniques | 1 | 1992 | 20 | 0.030 |
Why?
| | Coombs Test | 1 | 1992 | 5 | 0.030 |
Why?
| | Volition | 2 | 2003 | 32 | 0.030 |
Why?
| | Pregnancy | 3 | 1992 | 6423 | 0.030 |
Why?
| | Histocompatibility Testing | 1 | 1992 | 121 | 0.020 |
Why?
| | Mass Spectrometry | 2 | 2007 | 717 | 0.020 |
Why?
| | Citrate (si)-Synthase | 2 | 2003 | 58 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 2000 | 999 | 0.020 |
Why?
| | Molecular Typing | 1 | 2011 | 21 | 0.020 |
Why?
| | Sequence Analysis, DNA | 2 | 2007 | 778 | 0.020 |
Why?
| | Daptomycin | 1 | 2011 | 19 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2000 | 1003 | 0.020 |
Why?
| | Leg | 1 | 2013 | 240 | 0.020 |
Why?
| | HLA Antigens | 1 | 1992 | 235 | 0.020 |
Why?
| | Rh Isoimmunization | 1 | 1991 | 3 | 0.020 |
Why?
| | Abnormalities, Multiple | 1 | 1992 | 175 | 0.020 |
Why?
| | Rh-Hr Blood-Group System | 1 | 1991 | 12 | 0.020 |
Why?
| | Vancomycin | 1 | 2011 | 78 | 0.020 |
Why?
| | Cell Cycle | 1 | 1993 | 583 | 0.020 |
Why?
| | Muscle Strength | 1 | 2013 | 304 | 0.020 |
Why?
| | Receptors, Fibronectin | 2 | 2000 | 6 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2011 | 349 | 0.020 |
Why?
| | Virulence Factors | 1 | 2011 | 157 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 5437 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2020 | 4077 | 0.020 |
Why?
| | Clonal Anergy | 1 | 2009 | 52 | 0.020 |
Why?
| | Rats, Wistar | 2 | 2001 | 443 | 0.020 |
Why?
| | Biofilms | 1 | 2011 | 245 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 170 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 1994 | 1951 | 0.020 |
Why?
| | Oxidation-Reduction | 2 | 2003 | 1031 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2000 | 2045 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2011 | 486 | 0.020 |
Why?
| | Kinetics | 3 | 2000 | 1645 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2007 | 64 | 0.020 |
Why?
| | Genes, Regulator | 1 | 2007 | 35 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 508 | 0.020 |
Why?
| | Administration, Cutaneous | 1 | 2007 | 124 | 0.020 |
Why?
| | Cystatins | 1 | 2007 | 7 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2000 | 2344 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2007 | 179 | 0.020 |
Why?
| | Lipocalins | 1 | 2007 | 37 | 0.020 |
Why?
| | Cystatin C | 1 | 2007 | 65 | 0.020 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2007 | 68 | 0.020 |
Why?
| | Haptoglobins | 1 | 2007 | 53 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2007 | 131 | 0.020 |
Why?
| | Fibroblasts | 2 | 2003 | 954 | 0.020 |
Why?
| | Smoking Prevention | 1 | 2007 | 164 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2009 | 528 | 0.020 |
Why?
| | Immunoblotting | 1 | 2007 | 306 | 0.020 |
Why?
| | Nucleus Accumbens | 1 | 2007 | 128 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2009 | 1110 | 0.020 |
Why?
| | Cell Division | 2 | 2000 | 790 | 0.010 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2005 | 38 | 0.010 |
Why?
| | Nicotine | 1 | 2007 | 304 | 0.010 |
Why?
| | Albumins | 1 | 2005 | 104 | 0.010 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2005 | 70 | 0.010 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2005 | 81 | 0.010 |
Why?
| | Alcohol Withdrawal Delirium | 1 | 1984 | 8 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1984 | 94 | 0.010 |
Why?
| | Purpura | 1 | 2004 | 15 | 0.010 |
Why?
| | Exploratory Behavior | 1 | 1984 | 87 | 0.010 |
Why?
| | Isomerism | 1 | 2003 | 54 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2007 | 409 | 0.010 |
Why?
| | Genomics | 1 | 2008 | 716 | 0.010 |
Why?
| | Motor Skills | 1 | 1984 | 93 | 0.010 |
Why?
| | Muscle Cells | 1 | 2003 | 43 | 0.010 |
Why?
| | Protein Kinase C-epsilon | 1 | 2002 | 27 | 0.010 |
Why?
| | Peptide Mapping | 1 | 2002 | 64 | 0.010 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2002 | 17 | 0.010 |
Why?
| | RNA Precursors | 1 | 2003 | 148 | 0.010 |
Why?
| | CHO Cells | 1 | 2002 | 155 | 0.010 |
Why?
| | Coloring Agents | 1 | 2002 | 78 | 0.010 |
Why?
| | Cricetinae | 1 | 2002 | 280 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2005 | 634 | 0.010 |
Why?
| | Electrophoresis | 1 | 2001 | 31 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 2002 | 284 | 0.010 |
Why?
| | Animals, Suckling | 1 | 2000 | 10 | 0.010 |
Why?
| | Seizures | 1 | 1984 | 402 | 0.010 |
Why?
| | Blotting, Southern | 1 | 2000 | 70 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2002 | 1092 | 0.010 |
Why?
| | Basement Membrane | 1 | 2000 | 32 | 0.010 |
Why?
| | Autoimmune Diseases | 1 | 2004 | 428 | 0.010 |
Why?
| | Smoking | 1 | 2007 | 1502 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2002 | 585 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 2002 | 406 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1999 | 95 | 0.010 |
Why?
| | Putrescine | 1 | 1999 | 2 | 0.010 |
Why?
| | Oxaloacetic Acid | 1 | 1999 | 4 | 0.010 |
Why?
| | Virion | 1 | 2000 | 84 | 0.010 |
Why?
| | Acyl Coenzyme A | 1 | 1999 | 31 | 0.010 |
Why?
| | Formates | 1 | 1999 | 14 | 0.010 |
Why?
| | Citrates | 1 | 1999 | 43 | 0.010 |
Why?
| | Methylmalonic Acid | 1 | 1999 | 63 | 0.010 |
Why?
| | Citric Acid Cycle | 1 | 1999 | 55 | 0.010 |
Why?
| | Chemotaxis | 1 | 2000 | 130 | 0.010 |
Why?
| | Trehalose | 1 | 1999 | 31 | 0.010 |
Why?
| | Citric Acid | 1 | 1999 | 33 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 1999 | 296 | 0.010 |
Why?
| | Succinic Acid | 1 | 1999 | 39 | 0.010 |
Why?
| | Echocardiography | 1 | 2002 | 636 | 0.010 |
Why?
| | Pyruvic Acid | 1 | 1999 | 53 | 0.010 |
Why?
| | DNA, Single-Stranded | 1 | 2000 | 114 | 0.010 |
Why?
| | Keratinocytes | 1 | 2000 | 244 | 0.010 |
Why?
| | Protons | 1 | 1999 | 82 | 0.010 |
Why?
| | Carbon Isotopes | 1 | 1999 | 127 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2000 | 549 | 0.010 |
Why?
| | Alanine | 1 | 1999 | 143 | 0.010 |
Why?
| | Glycine | 1 | 1999 | 166 | 0.010 |
Why?
| | Neoplasm Invasiveness | 1 | 2000 | 484 | 0.010 |
Why?
| | Sex Factors | 1 | 1984 | 1973 | 0.010 |
Why?
| | DNA, Viral | 1 | 2000 | 347 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2000 | 931 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2000 | 610 | 0.010 |
Why?
| | Glutamic Acid | 1 | 1999 | 235 | 0.010 |
Why?
| | Hemodynamics | 1 | 2002 | 1094 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1999 | 541 | 0.010 |
Why?
| | Feedback | 1 | 1997 | 163 | 0.010 |
Why?
| | Cell Survival | 1 | 2000 | 1086 | 0.010 |
Why?
| | Exercise Test | 1 | 1999 | 614 | 0.010 |
Why?
| | Brain | 1 | 2007 | 2677 | 0.010 |
Why?
| | Succinate Dehydrogenase | 1 | 1995 | 46 | 0.010 |
Why?
| | Mass Screening | 1 | 2002 | 1192 | 0.010 |
Why?
| | Thymidine | 1 | 1993 | 60 | 0.010 |
Why?
| | Age Factors | 1 | 2001 | 3161 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 10241 | 0.010 |
Why?
| | Infant | 1 | 2007 | 9018 | 0.010 |
Why?
| | Glycerolphosphate Dehydrogenase | 1 | 1992 | 6 | 0.010 |
Why?
| | Insulin | 2 | 1993 | 2330 | 0.010 |
Why?
| | Child, Preschool | 1 | 2007 | 10522 | 0.010 |
Why?
| | Adipocytes | 1 | 1993 | 205 | 0.010 |
Why?
| | Biomechanical Phenomena | 1 | 1995 | 766 | 0.010 |
Why?
| | England | 1 | 1991 | 74 | 0.010 |
Why?
| | Collagen | 1 | 1992 | 438 | 0.010 |
Why?
| | Fetal Blood | 1 | 1991 | 318 | 0.000 |
Why?
| | Pregnancy Outcome | 1 | 1991 | 392 | 0.000 |
Why?
| | Middle Aged | 1 | 2007 | 31177 | 0.000 |
Why?
| | Incidence | 1 | 1991 | 2646 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1991 | 14553 | 0.000 |
Why?
|
|
Allen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|